🇺🇸 FDA
Patent

US 11149276

Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof

granted A61KA61K31/713A61K47/02

Quick answer

US patent 11149276 (Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Alnylam Pharmaceuticals, Inc.
Grant date
Tue Oct 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/713, A61K47/02, A61K9/08